The Value of Contrast-Enhanced Magnetic Resonance Imaging Enhancement in the Differential Diagnosis of Hepatocellular Carcinoma and Combined Hepatocellular Cholangiocarinoma

Figure 3

cHCC-CC presenting in a 51-year-old man. (a)-(b) nonsmooth tumor margin on T1WI, T2WI. (white arrow); (c) without obvious peritumoral enhancement in the arterial phase (yellow arrow); and (d) capsule obvious shows in enhanced portal phase images (red arrow).

(a)

(b)

(c)

(d)